Thumbnail Image
Publication

Mucosal biomarkers of colorectal cancer risk do not increase at 6 months following sleeve gastrectomy, unlike gastric bypass

Kant, P.
; 
Perry, S.L.
; 
Dexter, S.P.
; 
Race, Amanda D.
; 
Publication Date
2014-01
End of Embargo
Supervisor
Keywords
Colorectal cancer, obesity, Biomarkers, Cancer risk, Sleeve gastrectory
Rights
© 2014 The Authors. Obesity published by Wiley Periodicals, Inc. on behalf of The Obesity Society (TOS) This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
cb
Peer-Reviewed
Yes
Open Access status
openAccess
Accepted for publication
2013-04-05
Institution
Department
Awarded
Embargo end date
Collections
Life Sciences Publications
Show all metadata
Files
Thumbnail Image
kant_et_al_2014_obesity.pdf
Adobe PDF, 721.77 KB
Abstract
Objective The hypothesis that sleeve gastrectomy (SG) is not associated with an increase in mucosal colorectal cancer (CRC) biomarkers, unlike Roux-en-Y gastric bypass (RYGB), was tested. Design and Methods Rectal mucosa, blood, and urine were obtained from morbidly obese patients (n = 23) before and after (median 28 months) SG, as well as from nonobese controls (n = 20). Rectal epithelial cell mitosis and apoptosis, crypt size/fission, and pro-inflammatory gene expression were measured, as well as systemic inflammatory biomarkers, including C-reactive protein (CRP). Results The mean pre-operative body mass index in SG patients was 65.7 kg/m2 (24.7 kg/m2 in controls). Mean excess weight loss post-SG was 38.2%. There was a significant increase in mitosis frequency, crypt size, and crypt fission (all P < 0.01) in SG patients versus controls, as well as evidence of a chronic inflammatory state (raised CRP and mononuclear cell p65 NFκB binding), but there was no significant change in these biomarkers after SG, except CRP reduction. Macrophage migration inhibitory factor mRNA levels were increased by 39% post-SG (P = 0.038). Conclusions Mucosal biomarkers of CRC risk do not increase at 6 months following SG, unlike RYGB. Biomarkers of rectal crypt proliferation and systemic inflammation are increased in morbidly obese patients compared with controls.
URI
http://hdl.handle.net/10454/9997
Version
Published version
Citation
Kant P, Perry SL, Dexter SP, Race AD and Loadman PM (2014) Mucosal biomarkers of colorectal cancer risk do not increase at 6 months following sleeve gastrectomy, unlike gastric bypass. Obesity. 22(1): 202-210.
Link to publisher’s version
Link to published version
Link to Version of Record
https://doi.org/10.1002/oby.20493
Type
Article
Qualification name
Notes